CLO26-092: Real-World Use of Eflapegrastim in 14-Day Chemotherapy Cycles/Dose-Dense Regimens
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Fields of Study & Subjects
Neutropenia and Cancer Infections
Pharmacovigilance and Adverse Drug Reactions
Blood disorders and treatments
Publication details
- Journal / source
- Journal of the National Comprehensive Cancer Network
- Volume
- 24
- Issue
- 3.5
- Publication date
- 27 March 2026
- Language
- EN